Adults who lost weight with once-weekly injectable semaglutide or tirzepatide were able to maintain more than 70% of their ...
With another 2 million diverse patients, including some from RCTs, the calculators were effective at identifying those at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results